SCHEMBL9941754

SCHEMBL9941754

[CH2]Cc1cn(CCCC)cn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CPB2 Q96IY4 10/20 0.47
CPB1 P15086 4/20 0.47
TBXAS1 P24557 1/20 0.34
ALDH1A1 P00352 1/20 0.34
POLB P06746 1/20 0.34
KMT2A Q03164 1/20 0.34
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2A Q12879 1/20 0.33
GRIN2B Q13224 1/20 0.33
GRIN2C Q14957 1/20 0.33
GRIN3A Q8TCU5 1/20 0.33
LMNA P02545 1/20 0.33
ADORA2A P29274 1/20 0.32
CYP2C9 P11712 1/20 0.32
TSHR P16473 1/20 0.32
CYP2C19 P33261 1/20 0.32
MTOR P42345 1/20 0.32
HRH4 Q9H3N8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9939620 0.93 CPB2 (0.46) CPB2CPB1TBXAS1ALDH1A1POLB
SCHEMBL9941648 0.93 CPB2 (0.46) CPB2CPB1TBXAS1ALDH1A1POLB
SCHEMBL9939293 0.93 CPB2 (0.46) CPB2CPB1TBXAS1ALDH1A1POLB
SCHEMBL8934793 0.86 CPB2 (0.45) CPB2CPB1TBXAS1ALDH1A1POLB
SCHEMBL16992726 0.83 CPB2 (0.48) CPB2CPB1TBXAS1ALDH1A1POLB
Bromide SCHEMBL16738791 0.83 CPB2 (0.48) CPB2CPB1TBXAS1ALDH1A1POLB
SCHEMBL25653942 0.81 CPB2 (0.47) CPB2CPB1TBXAS1CYP2C9TSHR
SCHEMBL9939216 0.80
SCHEMBL4373193 0.80 CPB2 (0.46) CPB2CPB1TBXAS1POLBLMNA
SCHEMBL8795862 0.80 CPB2 (0.44) CPB2CPB1TBXAS1ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9402914-B2 Membrane lytic poly(amido amine) polymers for the delivery of oligonucleotides SIRNA THERAPEUTICS, INC. (US) 2016-08-02 US claimed
US-9402914-B2 Membrane lytic poly(amido amine) polymers for the delivery of oligonucleotides SIRNA THERAPEUTICS, INC. (US) 2016-08-02 US disclosed
US-20150165058-A1 MEMBRANE LYTIC POLY(AMIDO AMINE) POLYMERS FOR THE DELIVERY OF OLIGONUCLEOTIDES BANK OF AMERICA, N.A. 2015-06-18 US disclosed
US-8901101-B2 Membrane lytic poly(amido amine) polymers for the delivery of oligonucleotides SIRNA THERAPEUTICS, INC. (US) 2014-12-02 US disclosed
US-20130289207-A1 MEMBRANE LYTIC POLY(AMIDO AMINE) POLYMERS FOR THE DELIVERY OF OLIGONUCLEOTIDES BANK OF AMERICA, N.A. 2013-10-31 US disclosed
WO-2012082574-A1 MEMBRANE LYTIC POLY(AMIDO AMINE) POLYMERS FOR THE DELIVERY OF OLIGONUCLEOTIDES MERCK SHARP & DOHME CORP. (US) 2012-06-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150165058-A1 MEMBRANE LYTIC POLY(AMIDO AMINE) POLYMERS FOR THE DELIVERY OF OLIGONUCLEOTIDES PUF60, PHOSPHO1, PARG CPB2 1157/4885CPB1 705/4885TBXAS1 4152/4885
US-20130289207-A1 MEMBRANE LYTIC POLY(AMIDO AMINE) POLYMERS FOR THE DELIVERY OF OLIGONUCLEOTIDES PUF60, PHOSPHO1, PARG CPB2 1157/4885CPB1 705/4885TBXAS1 4152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.